ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Cipla receives final approval for generic version of AstraZeneca Pharmaceutical's Nexium (Esomeprazole for oral suspension 10mg, 20mg and 40mg)

Mumbai (Maharashtra) [India], Mar 27 (ANI/ PRNewswire): Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla" today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole for Oral Suspension 10mg, 20mg and 40mg from the United States Food and Drug Administration (US FDA). Cipla is the first company to file for the 10mg strength.

ANI Mar 27, 2020 19:16 IST googleads

Cipla receives final approval for generic version of AstraZeneca Pharmaceutical's Nexium (Esomeprazole for oral suspension 10mg, 20mg and 40mg)

Mumbai (Maharashtra) [India], Mar 27 (ANI/ PRNewswire): Cipla Limited today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Esomeprazole for Oral Suspension 10mg, 20mg and 40mg from the United States Food and Drug Administration (US FDA). Cipla is the first company to file for the 10mg strength.
Cipla's Esomeprazole for Oral Suspension 10mg, 20mg and 40mg is AB-rated generic therapeutic equivalent version of AstraZeneca Pharmaceutical's Nexium. It is a proton pump inhibitor indicated for the treatment of gastroesophageal reflux disease (GERD), risk reduction of NSAID-associated gastric ulcer, H. pylori eradication to reduce the risk of duodenal ulcer recurrence and pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
According to IQVIA (IMS Health), Nexium and its generic equivalents had US sales of approximately USD 70M for the 12-month period ending November 2019. The product is available for shipping immediately.
This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/ PRNewswire)

Get the App

What to Read Next

Business

Piyush Goyal meets global industry leaders to deepen trade ties

Piyush Goyal meets global industry leaders to deepen trade ties

The meetings were inclined towards bolstering India's manufacturing capabilities and deepening its integration into global supply chains. The discussions focused on expanding investment partnerships and enhancing India's role as a critical hub in the Indo-Pacific region.

Read More
Business

India market "relatively resilient" compared to its Asian peers

India market

The deepening conflict in West Asia has placed the Indian economy and the broader Asian region in the "eye of the storm," as supply chain disruptions and surging energy costs threaten to trigger a significant negative growth shock.

Read More
Business

Adani Foundation to connect 10 lakh women nationwide

Adani Foundation to connect 10 lakh women nationwide

The Adani Foundation, today, declared that in the next one year, it will connect one lakh women in Maharashtra with the Swabhimaan initiative. For the future, Adani Foundation has announced to connect 10 lakh women in India with the same initiative and make them strong.

Read More
Business

Govt Urges Citizens to Avoid Panic Booking

Govt Urges Citizens to Avoid Panic Booking

Amid global energy disruptions following the closure of the Strait of Hormuz, the government has assured that the domestic supply of LPG, petrol, diesel, kerosene, and natural gas remains stable, while citizens are urged to avoid panic booking and conserve fuel, said Sujata Sharma, Joint Secretary of the Ministry of Petroleum and Natural Gas, today.

Read More
Business

India Emerging as Stable Investment Anchor in Turbulent Global

India Emerging as Stable Investment Anchor in Turbulent Global

Mumbai (Maharashtra) [India], March 12: As military conflict in West Asia disrupts energy supplies through the Strait of Hormuz and global liquidity tightens, leading investors, policymakers and capital markets leaders gathered at IGF Mumbai 2026: Catalysing Capital to assess India's position in an increasingly fragmented global economy.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.